{"product_id":"retatrutide-40mg-caneta-thera-genetics","title":"Retatrutide 40mg, Caneta Injetável GLP-1, GIP e Glucagon - Thera Genetics","description":"\u003cp style=\"margin-block: 0px 0.9rem; margin-bottom: 20px; color: rgb(132, 142, 159); font-family: Roboto, sans-serif; font-size: 14px; outline: none !important;\"\u003e\u003cfont dir=\"auto\" style=\"vertical-align: inherit; outline: none !important;\"\u003eMecanismo de ação:\u003c\/font\u003e\u003cbr style=\"outline: none !important;\"\u003e\u003cfont dir=\"auto\" style=\"vertical-align: inherit; outline: none !important;\"\u003eA retatrutida é um triplo agonista dos receptores de GLP-1, GIP e glucagon. Essa combinação atua de forma integrada para reduzir o apetite e aumentar a saciedade, melhorar a homeostase glicêmica e promover maior gasto energético\/termogênese por meio da atividade no receptor de glucagon.\u003c\/font\u003e\u003c\/p\u003e\u003cp style=\"margin-block: 0px 0.9rem; margin-bottom: 20px; color: rgb(132, 142, 159); font-family: Roboto, sans-serif; font-size: 14px; outline: none !important;\"\u003e\u003cfont dir=\"auto\" style=\"vertical-align: inherit; outline: none !important;\"\u003ePrincipais benefícios\u003c\/font\u003e\u003cbr style=\"outline: none !important;\"\u003e\u003cfont dir=\"auto\" style=\"vertical-align: inherit; outline: none !important;\"\u003e: - Redução significativa do peso corporal em estudos clínicos, com resultados de alto impacto na obesidade.\u003c\/font\u003e\u003cbr style=\"outline: none !important;\"\u003e\u003cfont dir=\"auto\" style=\"vertical-align: inherit; outline: none !important;\"\u003e- Melhora do controle glicêmico e dos marcadores cardiometabólicos (por exemplo, lipídios inflamatórios e pressão arterial relatados nos resultados).\u003c\/font\u003e\u003cbr style=\"outline: none !important;\"\u003e\u003cfont dir=\"auto\" style=\"vertical-align: inherit; outline: none !important;\"\u003e- Redução da gordura hepática e melhorias associadas à doença hepática metabólica (MASLD\/MASH) em um estudo de Fase 2a.\u003c\/font\u003e\u003cbr style=\"outline: none !important;\"\u003e\u003cfont dir=\"auto\" style=\"vertical-align: inherit; outline: none !important;\"\u003e- Qualidade da perda de peso (composição corporal): evidências sugerem uma maior redução da massa gorda, sem um aumento desproporcional na perda de massa magra, em subestudos de composição corporal.\u003c\/font\u003e\u003cbr style=\"outline: none !important;\"\u003e\u003cfont dir=\"auto\" style=\"vertical-align: inherit; outline: none !important;\"\u003e- Perfil de tolerabilidade consistente com a classe das incretinas, com eventos gastrointestinais relatados com maior frequência nos estudos (por exemplo, náuseas, diarreia e constipação).\u003c\/font\u003e\u003c\/p\u003e\u003cp data-start=\"412\" data-end=\"449\" style=\"margin-block: 0px 0.9rem; margin-bottom: 20px; color: rgb(132, 142, 159); font-family: Roboto, sans-serif; font-size: 14px; outline: none !important;\"\u003e\u003cspan style=\"font-weight: bolder; outline: none !important;\"\u003e\u003cfont dir=\"auto\" style=\"vertical-align: inherit; outline: none !important;\"\u003eDOSAGEM UTILIZADA EM ESTUDOS DE FASE 3\u003c\/font\u003e\u003c\/span\u003e\u003c\/p\u003e\u003cp data-start=\"451\" data-end=\"560\" style=\"margin-block: 0px 0.9rem; margin-bottom: 20px; color: rgb(132, 142, 159); font-family: Roboto, sans-serif; font-size: 14px; outline: none !important;\"\u003e\u003cfont dir=\"auto\" style=\"vertical-align: inherit; outline: none !important;\"\u003eNos estudos mais recentes do \u003c\/font\u003e\u003cspan data-start=\"487\" data-end=\"518\" style=\"font-weight: bolder; outline: none !important;\"\u003e\u003cfont dir=\"auto\" style=\"vertical-align: inherit; outline: none !important;\"\u003eprograma TRIUMPH (Fase 3)\u003c\/font\u003e\u003c\/span\u003e\u003cfont dir=\"auto\" style=\"vertical-align: inherit; outline: none !important;\"\u003e , a retatrutida foi administrada da seguinte forma:\u003c\/font\u003e\u003c\/p\u003e\u003cul data-start=\"561\" data-end=\"668\" style=\"outline: 0px; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; border: 0px; margin-block: 0px; vertical-align: baseline; margin-bottom: 20px; color: rgb(132, 142, 159); font-family: Roboto, sans-serif;\"\u003e\n\u003cli data-start=\"561\" data-end=\"588\" style=\"outline: 0px; background: transparent; border: 0px; margin-block: 0px; vertical-align: baseline;\"\u003e\u003cp data-start=\"563\" data-end=\"588\" style=\"margin-block: 0px 0.9rem; margin-bottom: 20px; outline: none !important;\"\u003e\u003cspan data-start=\"563\" data-end=\"573\" style=\"font-weight: bolder; outline: none !important;\"\u003e\u003cfont dir=\"auto\" style=\"vertical-align: inherit; outline: none !important;\"\u003eVia de administração:\u003c\/font\u003e\u003c\/span\u003e\u003cfont dir=\"auto\" style=\"vertical-align: inherit; outline: none !important;\"\u003e Subcutânea\u003c\/font\u003e\u003c\/p\u003e\u003c\/li\u003e\n\u003cli data-start=\"589\" data-end=\"619\" style=\"outline: 0px; background: transparent; border: 0px; margin-block: 0px; vertical-align: baseline;\"\u003e\u003cp data-start=\"591\" data-end=\"619\" style=\"margin-block: 0px 0.9rem; margin-bottom: 20px; outline: none !important;\"\u003e\u003cspan data-start=\"591\" data-end=\"605\" style=\"font-weight: bolder; outline: none !important;\"\u003e\u003cfont dir=\"auto\" style=\"vertical-align: inherit; outline: none !important;\"\u003eFrequência:\u003c\/font\u003e\u003c\/span\u003e\u003cfont dir=\"auto\" style=\"vertical-align: inherit; outline: none !important;\"\u003e Uma vez por semana\u003c\/font\u003e\u003c\/p\u003e\u003c\/li\u003e\n\u003cli data-start=\"620\" data-end=\"668\" style=\"outline: 0px; background: transparent; border: 0px; margin-block: 0px; vertical-align: baseline;\"\u003e\u003cp data-start=\"622\" data-end=\"668\" style=\"margin-block: 0px 0.9rem; margin-bottom: 20px; outline: none !important;\"\u003e\u003cspan data-start=\"622\" data-end=\"641\" style=\"font-weight: bolder; outline: none !important;\"\u003e\u003cfont dir=\"auto\" style=\"vertical-align: inherit; outline: none !important;\"\u003eDuração do estudo:\u003c\/font\u003e\u003c\/span\u003e\u003cfont dir=\"auto\" style=\"vertical-align: inherit; outline: none !important;\"\u003e Aproximadamente \u003c\/font\u003e\u003cspan data-start=\"656\" data-end=\"668\" style=\"font-weight: bolder; outline: none !important;\"\u003e\u003cfont dir=\"auto\" style=\"vertical-align: inherit; outline: none !important;\"\u003e68 semanas\u003c\/font\u003e\u003c\/span\u003e\u003c\/p\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\u003chr data-start=\"670\" data-end=\"673\" style=\"box-sizing: border-box; overflow: visible; border-color: rgb(234, 234, 234); margin: 0px; font-family: Roboto, sans-serif; outline: none !important;\"\u003e\u003cp style=\"margin-block: 0px 0.9rem; margin-bottom: 20px; color: rgb(132, 142, 159); font-family: Roboto, sans-serif; font-size: 14px; outline: none !important;\"\u003e\u003cspan style=\"font-weight: bolder; outline: none !important;\"\u003e\u003cfont dir=\"auto\" style=\"vertical-align: inherit; outline: none !important;\"\u003eDosagem recomendada (Modelo de escalonamento de pesquisa clínica)\u003c\/font\u003e\u003c\/span\u003e\u003c\/p\u003e\u003cp style=\"margin-block: 0px 0.9rem; margin-bottom: 20px; color: rgb(132, 142, 159); font-family: Roboto, sans-serif; font-size: 14px; outline: none !important;\"\u003e\u003cfont dir=\"auto\" style=\"vertical-align: inherit; outline: none !important;\"\u003eA retatrutida é administrada uma vez por semana, com aumento gradual da dose para melhorar a tolerabilidade.\u003c\/font\u003e\u003c\/p\u003e\u003cp style=\"margin-block: 0px 0.9rem; margin-bottom: 20px; color: rgb(132, 142, 159); font-family: Roboto, sans-serif; font-size: 14px; outline: none !important;\"\u003e\u003cspan style=\"font-weight: bolder; outline: none !important;\"\u003e\u003cfont dir=\"auto\" style=\"vertical-align: inherit; outline: none !important;\"\u003eEstrutura de escalonamento de dose\u003c\/font\u003e\u003c\/span\u003e\u003c\/p\u003e\u003cp style=\"margin-block: 0px 0.9rem; margin-bottom: 20px; color: rgb(132, 142, 159); font-family: Roboto, sans-serif; font-size: 14px; outline: none !important;\"\u003e\u003cfont dir=\"auto\" style=\"vertical-align: inherit; outline: none !important;\"\u003eDose semanal por fase:\u003c\/font\u003e\u003cbr style=\"outline: none !important;\"\u003e\u003cfont dir=\"auto\" style=\"vertical-align: inherit; outline: none !important;\"\u003eSemanas 1–4: 1 mg;\u003c\/font\u003e\u003cbr style=\"outline: none !important;\"\u003e\u003cfont dir=\"auto\" style=\"vertical-align: inherit; outline: none !important;\"\u003eSemanas 5–8: 2 mg\u003c\/font\u003e\u003cbr style=\"outline: none !important;\"\u003e\u003cfont dir=\"auto\" style=\"vertical-align: inherit; outline: none !important;\"\u003e; Semanas 9–12: 4 mg\u003c\/font\u003e\u003c\/p\u003e\u003cp style=\"margin-block: 0px 0.9rem; margin-bottom: 20px; color: rgb(132, 142, 159); font-family: Roboto, sans-serif; font-size: 14px; outline: none !important;\"\u003e\u003cfont dir=\"auto\" style=\"vertical-align: inherit; outline: none !important;\"\u003eDose de manutenção (faixa de pesquisa): 6–8 mg\u003c\/font\u003e\u003c\/p\u003e\u003cp style=\"margin-block: 0px 0.9rem; margin-bottom: 20px; color: rgb(132, 142, 159); font-family: Roboto, sans-serif; font-size: 14px; outline: none !important;\"\u003e \u003c\/p\u003e\u003cp style=\"margin-block: 0px 0.9rem; margin-bottom: 20px; color: rgb(132, 142, 159); font-family: Roboto, sans-serif; font-size: 14px; outline: none !important;\"\u003e\u003cfont dir=\"auto\" style=\"vertical-align: inherit; outline: none !important;\"\u003e\u003c\/font\u003e\u003c\/p\u003e\u003cp style=\"margin-block: 0px 0.9rem; margin-bottom: 20px; color: rgb(132, 142, 159); font-family: Roboto, sans-serif; font-size: 14px; outline: none !important;\"\u003e\u003cfont dir=\"auto\" style=\"vertical-align: inherit; outline: none !important;\"\u003eEnsaios clínicos avaliaram doses de até \u003c\/font\u003e\u003cspan style=\"font-weight: bolder; outline: none !important;\"\u003e\u003cfont dir=\"auto\" style=\"vertical-align: inherit; outline: none !important;\"\u003e12 mg uma vez por semana,\u003c\/font\u003e\u003c\/span\u003e\u003cfont dir=\"auto\" style=\"vertical-align: inherit; outline: none !important;\"\u003e com titulação gradual.\u003c\/font\u003e\u003c\/p\u003e","brand":"Thera Genetics","offers":[{"title":"Default Title","offer_id":43529321840699,"sku":"THER-RETA40PEN","price":2590.9,"currency_code":"BRL","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0658\/9952\/8251\/files\/retatrutide-40mg-caneta-thera-genetics-peptideo-845.webp?v=1779208331","url":"https:\/\/peptideosdobrasil.com.br\/products\/retatrutide-40mg-caneta-thera-genetics","provider":"Peptideos do Brasil","version":"1.0","type":"link"}